The global dental membrane and bone graft substitutes market, valued at US$ 500 million in 2020, is projected to reach US$ 900 million by 2031, expanding at a CAGR of 8%. This growth is driven by the rising incidence of oral disorders, such as periodontal diseases and oral cancer, affecting 3.5 billion people globally, according to WHO. Increasing demand for dental implants, growing awareness of oral hygiene, and frequent product launches fuel market expansion. Resorbable dental membranes, particularly collagen-based, are gaining popularity due to their cost-effectiveness and ability to promote tissue regeneration. The market faces challenges from the COVID-19 pandemic’s impact on elective procedures and supply chain disruptions, but recovery is expected by 2022, supported by advancements in dental technologies.

For More Insights, Request a Sample of this Report:

https://www.factmr.com/connectus/sample?flag=S&rep_id=6475

Market Analysis

The dental membrane and bone graft substitutes market is propelled by a global surge in dental implant procedures, driven by increasing oral health issues like dental caries and gum disease. Human cell sources and other species-based grafts held a 75% market share in 2020, reflecting their widespread use in implant procedures. Dental tourism in countries like Mexico, Hungary, India, and China boosts demand by offering cost-effective, high-quality services. However, the COVID-19 pandemic disrupted production and delayed elective surgeries, impacting supply chains, particularly due to reliance on Chinese raw materials. Despite these challenges, growing healthcare expenditure and consumer awareness of dental care are driving recovery. The market is supported by strategic expansions, such as Danaher’s 2017 acquisition of Implant Direct and Straumann’s 2018 investment in botiss biomaterials, enhancing product portfolios and distribution networks.

Segment Analysis

The market is segmented by type, material, end user, and region. Resorbable dental membranes lead due to their cost-effectiveness and elimination of removal procedures, with collagen-based membranes particularly favored for tissue regeneration. Allografts and autografts are widely used, while synthetic and xenograft substitutes cater to niche demands. By material, human cell sources dominate, followed by collagen and hydroxyapatite, with tricalcium phosphate gaining traction for its biocompatibility. Dental clinics are the primary end users, driven by the preference for specialized group practices and the rising number of implant procedures. Europe holds the largest market share, expanding at a 5% CAGR, due to its advanced healthcare infrastructure and high implant volumes (5–6 million in 2020). North America, led by the U.S., accounts for 30% of global demand, while East Asia, particularly China, shows strong growth potential.

Country-wise Insights

The U.S. market, valued at over US$ 130 million in 2020, is driven by high awareness and affordability, with 23 million people completely edentulous and 12 million edentulous in one arch, per the American College of Prosthodontists. Europe, particularly Germany and the UK, leads globally due to robust healthcare systems and increasing periodontal awareness. China, projected to reach US$ 200 million by 2031, benefits from a 6% GDP healthcare spend, lenient regulations, and a booming dental tourism sector. India and Japan, with a 4% CAGR each, are emerging markets due to improving healthcare infrastructure and rising cosmetic dentistry demand. South Korea also shows steady growth, supported by increasing dental procedure adoption and insurance coverage expansion.

Key Players

• Geistlich Pharma
• Zimmer Biomet
• Integra LifeSciences
• BioHorizons
• Osteogenics
• Nobel Biocare
• Implant Direct
• Collagen Matrix
• Institut Straumann AG
• Dentsply Sirona
• Maxigen Biotech
• ACE Surgical Supply Company
• Citagenix, Inc
• RTI Surgical Holdings

Strategic Outlook and Industry Trends

The dental membrane and bone graft substitutes market is poised for robust growth through 2031, driven by innovations in resorbable membranes and biocompatible materials. Companies are focusing on strategic acquisitions and partnerships, such as Straumann’s stake in botiss biomaterials, to enhance product offerings. The rise of dental tourism and cosmetic dentistry, particularly in Asia, supports market expansion. Challenges like supply chain disruptions are being mitigated through diversified sourcing and technological advancements. Increasing focus on post-treatment evaluations and bone graft assessments will further drive demand. Top players, holding 40% of the market, are investing in R&D to develop advanced materials, ensuring sustained growth and competitiveness.

Segmentation of Dental Membrane and Bone Graft Substitutes Market

By Type:

• Resorbable Dental Membrane and Bone Graft Substitutes
• Non-resorbable Dental Membrane and Bone Graft Substitutes
• Autograft Dental Membrane and Bone Graft Substitutes
• Allograft Dental Membrane and Bone Graft Substitutes
• Xenograft Dental Membrane and Bone Graft Substitutes
• Synthetic Dental Membrane and Bone Graft Substitutes

By Material:

• Hydrogel Dental Membrane and Bone Graft Substitutes
• Collagen Dental Membrane and Bone Graft Substitutes
• Human Cells Source Dental Membrane and Bone Graft Substitutes
• Hydroxyapatite Dental Membrane and Bone Graft Substitutes
• Tricalcium Phosphate Dental Membrane and Bone Graft Substitutes

By End User:

• Dental Clinics
• Hospitals
• Ambulatory Surgical Centers

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia & Oceania
• Middle East & Africa

Explore More Related Studies Published by Fact.MR Research:

GLP-1 Market

https://www.einpresswire.com/article/817481612/glp-1-market-set-to-surge-at-17-3-cagr-to-reach-us-324-5-billion-by-2035-fact-mr-report

Bipolar Disorder Therapeutics Market

https://www.einpresswire.com/article/821452926/bipolar-disorder-therapeutics-market-to-reach-usd-10-970m-by-2035-fact-mr-report

Contact

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Email: sales@factmr.com